Ireland · Seed startup

Who invested in NoFrixion

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Fintech

Funding summaryUpdated 26 Oct 2026

$3.5Mraised across 1 round since 2022, from 1 source

Latest round
Seed, $3.5MOct 2022
Investors
1
See who backed them

The rounds

  1. Oct 2022
    Seed$3.5M

    Source recorded

Founders and team

From NoFrixion's own website: 11 on the team.

  • Feargal BradyCEO
  • Aaron ClausonCTO / Cio
  • Kam ToorChief Risk Officer
  • Andrés GonzálezHead of Product
  • Brian QuigleyHead of Finance
  • Michael CulliganDirector of Strategy & Head of Compliance
  • Pablo IbañezHead of Design
  • Kate HottenChair of Risk Committee.
  • Kieran McLoughlinChair
  • Maurice RocheNon-executive Director
  • Patrick PinschmidtNon-executive Director

Everyone who backed them

Delta PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists NoFrixion as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Furthr VCVC firmPer its own site

Quick answers about NoFrixion

Who invested in NoFrixion?

NoFrixion's investors include Delta Partners.

How much has NoFrixion raised?

NoFrixion has raised $3.5M across 1 round since 2022.

When did NoFrixion last raise?

NoFrixion's most recent round was a Seed of $3.5M in Oct 2022.

What was NoFrixion's biggest round?

Its most recent round, $3.5M in Oct 2022, is also its largest on record.

Who backed NoFrixion first?

NoFrixion's first round on record, in Oct 2022, was backed by Delta Partners.

What stage is NoFrixion at?

NoFrixion's latest named round is a Seed, in Oct 2022.

Where is NoFrixion based?

NoFrixion is based in Ireland.

Companies like NoFrixion

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.